Antithrombotic use amongst patients at low stroke risk as defined by the CHA2DS2-VASc score: Insight from the prospective SPRINT-AF registry
28 August 2017 (08:30 - 12:30)
Organised by:
Abstract
About the speaker
University of Toronto, Toronto (Canada)
53 More presentations in this session
Access the full session
The Event
ESC Congress 2017
28 August 2017
08:30 CET
